Upper airway infections, particularly chronic sinus infection impacts more than 30 million Americans and incurs an annual multi-billion dollar health care burden. We are currently engaged in studies examining the role of the sinus microbiome in either mediating or protecting against both acute and chronic sinusitis. We are also examining in pediatric populations, how perturbation to microbial communities in this niche may lead to aberrant community reassembly and chronic disease development.